Table 2.

Impact of transcatheter edge-to-edge repair on primary endpoints in RESHAPE-HF2

	Impact on outcome	P-value
Primary endpoints
Rate of heart failure hospitalizations or CV death (at 24 months)	36% ↓ in risk	0.002
Rate of recurrent heart failure hospitalizations (at 24 months)	41% ↓ in risk	0.002
KCCQ overall summary score (at 12 months)	11 points ↑ in QoL	<0.0001
Secondary endpoints
NYHA Class I/II (at 12 months)	2.35 more likely	<0.0001
6-min walking test distance (at 12 months)	20.5 m ↑ performance	0.046

CV, cardiovascular; KCCQ, Kansas City Cardiomyopathy Questionnaire; NYHA, New York Heart Association.